- Home
- OABI vs TYG Comparison
OABI vs TYG Comparison
Compare OABI & TYG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- TYG
- Stock Information
- Founded
- OABI 2012
- TYG 2003
- Country
- OABI United States
- TYG United States
- Employees
- OABI N/A
- TYG N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- TYG Investment Managers
- Sector
- OABI Health Care
- TYG Finance
- Exchange
- OABI Nasdaq
- TYG Nasdaq
- Market Cap
- OABI 459.1M
- TYG 429.9M
- IPO Year
- OABI N/A
- TYG N/A
- Fundamental
- Price
- OABI $4.53
- TYG $41.77
- Analyst Decision
- OABI Strong Buy
- TYG
- Analyst Count
- OABI 4
- TYG 0
- Target Price
- OABI $9.00
- TYG N/A
- AVG Volume (30 Days)
- OABI 349.2K
- TYG 22.8K
- Earning Date
- OABI 11-12-2024
- TYG 01-01-0001
- Dividend Yield
- OABI N/A
- TYG 7.47%
- EPS Growth
- OABI N/A
- TYG N/A
- EPS
- OABI N/A
- TYG 9.77
- Revenue
- OABI $21,714,000.00
- TYG $13,618,248.00
- Revenue This Year
- OABI N/A
- TYG N/A
- Revenue Next Year
- OABI $71.78
- TYG N/A
- P/E Ratio
- OABI N/A
- TYG $4.18
- Revenue Growth
- OABI N/A
- TYG N/A
- 52 Week Low
- OABI $3.56
- TYG $27.44
- 52 Week High
- OABI $6.72
- TYG $41.86
- Technical
- Relative Strength Index (RSI)
- OABI 73.77
- TYG 66.79
- Support Level
- OABI $4.04
- TYG $39.90
- Resistance Level
- OABI $4.87
- TYG $40.74
- Average True Range (ATR)
- OABI 0.18
- TYG 0.61
- MACD
- OABI 0.10
- TYG -0.04
- Stochastic Oscillator
- OABI 86.09
- TYG 95.43
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.